Compounds > 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
Page last updated: 2024-09-04

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Colonic Neoplasms

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dohi, K; Matsuyama, T; Nishimura, Y; Tahara, E; Yasui, W; Yoshida, K1

Other Studies

1 other study(ies) available for 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Colonic Neoplasms

ArticleYear
A serine protease-inhibitory benzamidine derivative inhibits the growth of human colon carcinoma cells.
    Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:7

    Topics: Antineoplastic Agents; Benzamidines; Cell Division; Colonic Neoplasms; Growth Substances; Humans; Inositol 1,4,5-Trisphosphate; Oncogenes; Protein Kinase C; Receptors, Somatotropin; Serine Proteinase Inhibitors; Tumor Cells, Cultured

1992